Shenzhen Historical Cash Flow
| 300942 Stock | 9.88 0.74 6.97% |
Analysis of Shenzhen Bioeasy cash flow over time is an excellent tool to project Shenzhen Bioeasy Bio future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 191.6 M or Capital Expenditures of 81 M as it is a great indicator of Shenzhen Bioeasy ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Shenzhen Bioeasy Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Shenzhen Bioeasy Bio is a good buy for the upcoming year.
Shenzhen |
About Shenzhen Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Shenzhen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shenzhen's non-liquid assets can be easily converted into cash.
Shenzhen Bioeasy Cash Flow Chart
Add Fundamental
Capital Expenditures
Capital Expenditures are funds used by Shenzhen Bioeasy Bio to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Shenzhen Bioeasy operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Most accounts from Shenzhen Bioeasy's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Shenzhen Bioeasy Bio current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shenzhen Bioeasy Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Shenzhen Bioeasy's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Other Cashflows From Financing Activities is expected to grow to about 191.6 M, whereas Change In Working Capital is forecasted to decline to (32 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Other Non Cash Items | 6.2M | 8.0M | 26.1M | 27.4M | Depreciation | 24.2M | 30.4M | 33.5M | 20.6M |
Shenzhen Bioeasy cash flow statement Correlations
Click cells to compare fundamentals
Shenzhen Bioeasy Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Shenzhen Bioeasy cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 257.6M | (66.5M) | (35.0M) | (92.0M) | 234.6M | 246.3M | |
| Change In Working Capital | (80.6M) | (111.4M) | (144.8M) | (54.5M) | (30.4M) | (32.0M) | |
| Total Cashflows From Investing Activities | (9.0M) | (19.7M) | (73.8M) | (426.6M) | (383.9M) | (364.7M) | |
| Other Cashflows From Financing Activities | 34.1M | 209.3M | (46.2M) | 158.7M | 182.5M | 191.6M | |
| Capital Expenditures | 26.3M | 82.8M | 79.5M | 176.8M | 128.6M | 81.0M | |
| Total Cash From Operating Activities | 67.2M | 63.8M | 255.4M | 152.6M | (37.2M) | (35.4M) | |
| Total Cash From Financing Activities | 34.1M | 209.3M | (46.2M) | 140.6M | 161.7M | 169.8M | |
| Other Cashflows From Investing Activities | 1.6M | 6.6M | 9.0M | (347.1M) | (312.4M) | (296.7M) | |
| End Period Cash Flow | 440.8M | 374.2M | 339.2M | 247.2M | 481.7M | 378.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shenzhen Stock
The Cash Flow Statement is a financial statement that shows how changes in Shenzhen balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Shenzhen's non-liquid assets can be easily converted into cash.